GALECTIN THERAPEUTICS INC (GALT) Form 10-Q Quarterly Reports
GALECTIN THERAPEUTICS INC (GALT) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: GALT
CIK: 1133416
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: NV
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Cherry Bekaert LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerJessica Helms
Audit LocationAtlanta, Georgia, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| ARS | 2026-10-13 | 2025-12-31 | ARS | 0001140361-26-039381 | View SEC Doc Filr Page |
| DEFA14A | 2026-10-13 | — | DEFA14A | 0001140361-26-039380 | View SEC Doc Filr Page |
| DEF 14A | 2026-10-13 | 2026-12-03 | DEF 14A | 0001140361-26-039379 | View SEC Doc Filr Page |
| PRE 14A | 2026-10-02 | 2026-12-03 | PRE 14A | 0001140361-26-038402 | View SEC Doc Filr Page |
| 8-K | 2026-08-14 | 2026-08-14 | 8-K | 0001140361-26-032946 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001140361-26-032945 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-04 | — | SCHEDULE 13D/A Filing | 0001140361-26-031060 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-07-31 | FORM 4 | 0001133416-26-000065 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-07-31 | CURRENT REPORT FILING | 0001140361-26-031058 | View SEC Doc Filr Page |
| 4 | 2026-07-16 | 2026-07-14 | FORM 4 | 0001133416-26-000063 | View SEC Doc Filr Page |
| 4 | 2026-06-30 | 2026-06-26 | FORM 4 | 0001133416-26-000061 | View SEC Doc Filr Page |
| 4 | 2026-06-30 | 2026-06-26 | FORM 4 | 0001133416-26-000059 | View SEC Doc Filr Page |
| 144 | 2026-06-29 | — | 144 Filing | 0001628280-26-045997 | View SEC Doc Filr Page |
| 144 | 2026-06-26 | — | 144 Filing | 0001972481-26-000216 | View SEC Doc Filr Page |
| 144 | 2026-06-26 | — | 144 Filing | 0001628280-26-045766 | View SEC Doc Filr Page |
| 4 | 2026-06-25 | 2026-06-23 | FORM 4 | 0001133416-26-000057 | View SEC Doc Filr Page |
| 144 | 2026-06-23 | — | 144 Filing | 0001972481-26-000208 | View SEC Doc Filr Page |
| 8-K | 2026-06-23 | 2026-06-23 | 8-K | 0001140361-26-026031 | View SEC Doc Filr Page |
| 4 | 2026-05-28 | 2026-05-26 | FORM 4 | 0001133416-26-000055 | View SEC Doc Filr Page |
| 8-K | 2026-05-15 | 2026-05-15 | 8-K | 0001140361-26-021496 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | 10-Q | 0001140361-26-021495 | View SEC Doc Filr Page |
| EFFECT | 2026-04-10 | — | EFFECT Filing | 9999999995-26-001150 | View SEC Doc Filr Page |
| CORRESP | 2026-04-08 | — | CORRESP Filing | 0001140361-26-013760 | View SEC Doc Filr Page |
| UPLOAD | 2026-04-06 | — | UPLOAD Filing | 0000000000-26-003426 | View SEC Doc Filr Page |
| S-3 | 2026-03-31 | — | S-3 | 0001140361-26-012329 | View SEC Doc Filr Page |